Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey

Joseph C. Ratliff; Jessica A. Barber; Laura B. Palmese; Erin L. Reutenauer; Cenk Tek

doi:10.1038/oby.2010.176

journal article Dec 01, 2010

Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey

Joseph C. Ratliff Jessica A. Barber Laura B. Palmese Erin L. Reutenauer Cenk Tek

Obesity Vol. 18 No. 12 pp. 2398-2400 · Wiley

View at Publisher Save 10.1038/oby.2010.176

Abstract

The incidence of obesity in the United States has reached epidemic proportions. Previous research has shown several medications exert noticeable effects on body‐weight regulation. Histamine‐1 (H1) receptor blockers commonly used to alleviate allergy symptoms are known to report weight gain as a possible side effect. Therefore, we investigated the association between prescription H1 antihistamine use and obesity in adults using data from the 2005–2006 National Health and Nutrition Examination Survey (NHANES). Adults taking prescription H1 antihistamines were matched by age and gender with controls and compared on the basis of body measurements, plasma glucose, insulin concentrations, and lipid levels. Prescription H1 antihistamine users had a significantly higher weight, waist circumference, and insulin concentration than matched controls. The odds ratio (OR) for being overweight was increased in prescription H1 antihistamine users. H1 antihistamine use may contribute to the increased prevalence of obesity and the metabolic syndrome in adults given these medications are also commonly used as over‐the‐counter remedies.

Topics

No keywords indexed for this article. Browse by subject →

References

15

[1]

10.1001/jama.2009.2014

[2]

Clineschmidt BV "Histamine: intraventricular injection suppresses ingestive behavior of the cat" Arch Int Pharmacodyn Ther (1973)

[3]

10.1016/s0899-9007(97)91277-6

[4]

10.1152/physrev.00043.2007

[5]

10.1007/bf01993112

[6]

10.2165/00003495-198019040-00002

[7]

National Center for Health Statistics (2007)

[8]

10.1016/j.psyneuen.2008.01.018

[9]

10.1016/j.jaci.2008.12.1126

[10]

Falliers CJ "Double‐blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis" Ann Allergy (1991)

[11]

10.1016/0026-0495(95)90314-3

[12]

10.1016/j.chembiol.2004.04.017

[13]

Laurier V "Histamine stimulates glucose transport in rat adipocytes but not in human subcutaneous fat cells" Inflamm Res (2002) 10.1007/pl00022429

[14]

Ishikawa R "Insulin‐induced up‐regulation of histamine H1‐receptors" Inflamm Res (2002) 10.1007/pl00022455

[15]

10.2337/diabetes.50.2.385

Cited By

73

Integrative multi-omics analysis reveals oral microbiome-metabolome signatures of obesity

Ahmed A. Shibl, Tsedenia W. Denekew · 2026

Cell Reports

Management of Medication-Induced Weight Gain

Sarah R. Barenbaum, Rekha B. Kumar · 2023

Gastroenterology Clinics of North A...

Histamine and H1-antihistamines: Celebrating a century of progress

F. Estelle R. Simons, Keith J. Simons · 2011

Journal of Allergy and Clinical Imm...

Metrics

73

Citations

15

References

Details

Published: Dec 01, 2010
Vol/Issue: 18(12)
Pages: 2398-2400
License: View

Authors

Cite This Article

Joseph C. Ratliff, Jessica A. Barber, Laura B. Palmese, et al. (2010). Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey. Obesity, 18(12), 2398-2400. https://doi.org/10.1038/oby.2010.176

Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey

You May Also Like